Literature DB >> 25220403

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Rosalyn Jewell1, Faye Elliott, Jonathan Laye, Jérémie Nsengimana, John Davies, Christy Walker, Caroline Conway, Angana Mitra, Mark Harland, Martin G Cook, Andy Boon, Sarah Storr, Sabreena Safuan, Stewart G Martin, Karin Jirström, Håkan Olsson, Christian Ingvar, Martin Lauss, Tim Bishop, Göran Jönsson, Julia Newton-Bishop.   

Abstract

Ulceration of primary melanomas is associated with poor prognosis yet is reported to predict benefit from adjuvant interferon. To better understand the biological processes involved, clinicopathological factors associated with ulceration were determined in 1804 patients. From this cohort, 348 primary tumor blocks were sampled to generate gene expression data using a 502-gene cancer panel and 195 blocks were used for immunohistochemistry to detect macrophage infiltration and vessel density. Gene expression results were validated using a whole genome array in two independent sample sets. Ulceration of primary melanomas was associated with more proliferative tumors, tumor vessel invasion, and increased microvessel density. Infiltration of tumors with greater number of macrophages and gene expression pathways associated with wound healing and up-regulation of pro-inflammatory cytokines suggests that ulceration is associated with tumor-related inflammation. The relative benefit from interferon reported in patients with ulcerated tumors may reflect modification of signaling pathways involved in inflammation.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clinicopathological; gene expression; immunohistochemistry; melanoma; primary; ulceration

Mesh:

Year:  2014        PMID: 25220403      PMCID: PMC4276506          DOI: 10.1111/pcmr.12315

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  53 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Open source clustering software.

Authors:  M J L de Hoon; S Imoto; J Nolan; S Miyano
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

3.  Blood-vessel formation: Bridges that guide and unite.

Authors:  Thomas Schmidt; Peter Carmeliet
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 4.  The biology behind prognostic factors of cutaneous melanoma.

Authors:  Alan Spatz; Gerald Batist; Alexander M M Eggermont
Journal:  Curr Opin Oncol       Date:  2010-05       Impact factor: 3.645

5.  Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34.

Authors:  Amy E Rose; Paul J Christos; Dan Lackaye; Richard L Shapiro; Russell Berman; Madhu Mazumdar; Hideko Kamino; Iman Osman; Farbod Darvishian
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

6.  Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.

Authors:  Caroline Conway; Angana Mitra; Rosalyn Jewell; Juliette Randerson-Moor; Samira Lobo; Jérémie Nsengimana; Sara Edward; D Scott Sanders; Martin Cook; Barry Powell; Andy Boon; Faye Elliott; Floor de Kort; Margaret A Knowles; D Timothy Bishop; Julia Newton-Bishop
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

Review 7.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

8.  Angiogenesis is prognostically important in vertical growth phase melanomas.

Authors:  O Straume; H B Salvesen; L A Akslen
Journal:  Int J Oncol       Date:  1999-09       Impact factor: 5.650

9.  Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Authors:  Véronique Winnepenninckx; Vladimir Lazar; Stefan Michiels; Philippe Dessen; Marguerite Stas; Soledad R Alonso; Marie-Françoise Avril; Pablo L Ortiz Romero; Thomas Robert; Ovidiu Balacescu; Alexander M M Eggermont; Gilbert Lenoir; Alain Sarasin; Thomas Tursz; Joost J van den Oord; Alain Spatz
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

10.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

View more
  10 in total

1.  Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Authors:  Daniëlle Verver; Vichnou Poirier-Colame; Gorana Tomasic; Khadija Cherif-Rebai; Dirk J Grunhagen; Cornelis Verhoef; Stefan Suciu; Caroline Robert; Laurence Zitvogel; Alexander M M Eggermont
Journal:  Oncoimmunology       Date:  2019-09-06       Impact factor: 8.110

2.  Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

Authors:  Ellen H de Moll; Yichun Fu; Yingzhi Qian; Sara H Perkins; Shira Wieder; Sacha Gnjatic; Romain Remark; Sebastian G Bernardo; Marina Moskalenko; Jonathan Yao; Tammie Ferringer; Rui Chang; Jerry Chipuk; Basil A Horst; Miriam B Birge; Robert G Phelps; Yvonne M Saenger
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

3.  Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas.

Authors:  Lawrence N Kwong; Mariana Petaccia De Macedo; Lauren Haydu; Aron Y Joon; Michael T Tetzlaff; Tiffany L Calderone; Chiang-Jun Wu; Man Kam Kwong; Jason Roszik; Kenneth R Hess; Michael A Davies; Alexander J Lazar; Jeffrey E Gershenwald
Journal:  JCO Precis Oncol       Date:  2018-06-14

4.  Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.

Authors:  Linda Gao; Karin van den Hurk; Jérémie Nsengimana; Jonathan P Laye; Joost J van den Oord; Samuel Beck; Nelleke A Gruis; Willem H Zoutman; Manon van Engeland; Julia A Newton-Bishop; Véronique J Winnepenninckx; Remco van Doorn
Journal:  J Invest Dermatol       Date:  2015-04-28       Impact factor: 8.551

5.  Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.

Authors:  Daniela Cerezo-Wallis; Marta Contreras-Alcalde; Kevin Troulé; Xavier Catena; Cynthia Mucientes; Tonantzin G Calvo; Estela Cañón; Cristina Tejedo; Paula C Pennacchi; Sabrina Hogan; Peter Kölblinger; Héctor Tejero; Andrew X Chen; Nuria Ibarz; Osvaldo Graña-Castro; Lola Martinez; Javier Muñoz; Pablo Ortiz-Romero; José L Rodriguez-Peralto; Gonzalo Gómez-López; Fátima Al-Shahrour; Raúl Rabadán; Mitchell P Levesque; David Olmeda; María S Soengas
Journal:  Nat Med       Date:  2020-10-19       Impact factor: 87.241

6.  Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner.

Authors:  Tobias Bald; Jennifer Landsberg; Philipp Jansen; Evelyn Gaffal; Thomas Tüting
Journal:  Oncoimmunology       Date:  2015-09-01       Impact factor: 8.110

7.  β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.

Authors:  Jérémie Nsengimana; Jon Laye; Anastasia Filia; Sally O'Shea; Sathya Muralidhar; Joanna Poźniak; Alastair Droop; May Chan; Christy Walker; Louise Parkinson; Joanne Gascoyne; Tracey Mell; Minttu Polso; Rosalyn Jewell; Juliette Randerson-Moor; Graham P Cook; D Timothy Bishop; Julia Newton-Bishop
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

Review 8.  Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype.

Authors:  Zoe Barricklow; Mallory J DiVincenzo; Colin D Angell; William E Carson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-30

Review 9.  Vitamin D, vitamin A, the primary melanoma transcriptome and survival.

Authors:  S J O'Shea; J R Davies; J A Newton-Bishop
Journal:  Br J Dermatol       Date:  2016-10       Impact factor: 9.302

10.  NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2',2'-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer.

Authors:  Richard Daifuku; Sheila Grimes; Murray Stackhouse
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.